NCT07933094 Combined TECAR/EMS Therapy vs. Standard Manual Therapy for Endometriosis Pelvic Pain
| NCT ID | NCT07933094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | SWIMS America Corp. |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2026-11 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2026-11 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares two ways of delivering a combined radiofrequency (RET), muscle stimulation (Hi-EMS), and pulsed radiofrequency (Hi-TENS) therapy, hands-on by a physical therapist or hands-free using adhesive pads, and compares the combined therapy to hands-on manual therapy alone for pelvic pain in women with endometriosis. Participants attend 8 sessions over 6 weeks.
Eligibility Criteria
Inclusion Criteria: * Women age 18 or older with a diagnosis of endometriosis (surgical/histologic or imaging-based) * Pelvic pain attributable to endometriosis * Able to attend the 8-session outpatient schedule * Able to provide written informed consent Exclusion Criteria: * Clinical concern for or diagnosis of May-Thurner syndrome with associated risk of deep vein thrombosis (DVT) * Presence of a cardiac pacemaker, implantable cardioverter-defibrillator, or other active implanted electronic device * Active or suspected deep vein thrombosis or other uncontrolled clotting disorder * Open wound, active infection, or compromised skin integrity at planned electrode sites (suprapubic/lower abdominal region and sacral/gluteal region) * Known malignancy in the region to be treated * Current pregnancy * Inability to tolerate electrical stimulation per participant report during device calibration
Contact & Investigator
Melanie Carminati, PT, DPT, GTS, NCPT
PRINCIPAL INVESTIGATOR
Inspira Physical Therapy
Frequently Asked Questions
Who can join the NCT07933094 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07933094 currently recruiting?
Yes, NCT07933094 is actively recruiting participants. Contact the research team at melanie@inspirapt.com for enrollment information.
Where is the NCT07933094 trial being conducted?
This trial is being conducted at Brooklyn, United States.
Who is sponsoring the NCT07933094 clinical trial?
NCT07933094 is sponsored by SWIMS America Corp.. The principal investigator is Melanie Carminati, PT, DPT, GTS, NCPT at Inspira Physical Therapy. The trial plans to enroll 72 participants.